Dr. Martens PLC (LSE:DOCS) — Market Cap & Net Worth
Market Cap & Net Worth: Dr. Martens PLC (DOCS)
Dr. Martens PLC (LSE:DOCS) has a market capitalization of $9.10 Million (GBX74.81 Billion) as of August 1, 2026. Listed on the LSE stock exchange, this UK-based company holds position #27253 globally and #368 in its home market, demonstrating a 4.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dr. Martens PLC's stock price GBX77.40 by its total outstanding shares 966584199 (966.58 Million). See Dr. Martens PLC (DOCS) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Dr. Martens PLC Market Cap History: 2021 to 2026
Dr. Martens PLC's market capitalization history from 2021 to 2026. Data shows change from $45.96 Million to $9.10 Million (-26.16% CAGR).
Index Memberships
Dr. Martens PLC is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE All-Share
FTAS
|
$72.38 Billion | 0.01% | #272 of 573 |
|
FTSE 350
FTLC
|
$71.98 Billion | 0.01% | #261 of 350 |
|
FTSE 250
FTMC
|
$15.45 Billion | 0.06% | #174 of 250 |
Weight: Dr. Martens PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Dr. Martens PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dr. Martens PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Dr. Martens PLC's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.00x
Dr. Martens PLC's market cap is 2.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $45.96 Million | $773.00 Million | $34.70 Million | 0.06x | 1.32x |
| 2022 | $20.86 Million | $908.30 Million | $181.20 Million | 0.02x | 0.12x |
| 2023 | $10.09 Million | $1.00 Billion | $128.90 Million | 0.01x | 0.08x |
| 2024 | $8.49 Million | $877.10 Million | $69.20 Million | 0.01x | 0.12x |
| 2025 | $9.01 Million | $787.60 Million | $4.50 Million | 0.01x | 2.00x |
Competitor Companies of DOCS by Market Capitalization
Companies near Dr. Martens PLC in the global market cap rankings as of August 1, 2026.
Key companies related to Dr. Martens PLC by market ranking:
- Nike Inc (NYSE:NKE): Ranked #538 globally with a market cap of $50.03 Billion USD.
- adidas AG (F:ADS): Ranked #836 globally with a market cap of $32.11 Billion USD ( €27.46 Billion EUR).
- adidas AG (F:ADS1): Ranked #1075 globally with a market cap of $24.65 Billion USD ( €21.09 Billion EUR).
- ASICS CORP.(UNSP.ADR)/1 (F:ASI): Ranked #1463 globally with a market cap of $17.00 Billion USD ( €14.54 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #538 | Nike Inc | NYSE:NKE | $50.03 Billion | $41.71 |
| #836 | adidas AG | F:ADS | $32.11 Billion | €160.00 |
| #1075 | adidas AG | F:ADS1 | $24.65 Billion | €81.00 |
| #1463 | ASICS CORP.(UNSP.ADR)/1 | F:ASI | $17.00 Billion | €23.80 |
Dr. Martens PLC Historical Marketcap From 2021 to 2026
Between 2021 and today, Dr. Martens PLC's market cap moved from $45.96 Million to $ 9.10 Million, with a yearly change of -26.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX9.10 Million | +1.04% |
| 2025 | GBX9.01 Million | +6.09% |
| 2024 | GBX8.49 Million | -15.89% |
| 2023 | GBX10.09 Million | -51.61% |
| 2022 | GBX20.86 Million | -54.60% |
| 2021 | GBX45.96 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Dr. Martens PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.10 Million USD |
| MoneyControl | $9.10 Million USD |
| MarketWatch | $9.10 Million USD |
| marketcap.company | $9.10 Million USD |
| Reuters | $9.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dr. Martens PLC
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.